Review article · 2021 · Open access
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
The Lancet Neurology, 21(1), 66–77 · Published 24 November 2021 · DOI 10.1016/s1474-4422(21)00361-6
In brief
“Blood-based biomarkers for Alzheimer's disease: towards clinical implementation” is a 2021 review article by Charlotte Elisabeth Teunissen and 8 co-authors, published in The Lancet Neurology. OpenAlex counts 1,193 citations as of 19 November 2026, which puts it in the top 1% of works published in 2021 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Amsterdam UMC (VU Amsterdam) - Institutional Repository.
- Citations
- 1,193
- Most cited in
- 2026 (331)
- Field-weighted impact
- 21.45
- References
- 118
- Authors
- 9
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Teunissen, C. E., Verberk, I. M., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2021). Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. The Lancet Neurology, 21(1), 66–77. https://doi.org/10.1016/s1474-4422(21)00361-6
MLA 9
Teunissen, Charlotte Elisabeth, et al. “Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.” The Lancet Neurology, vol. 21, no. 1, 2021, pp. 66–77. https://doi.org/10.1016/s1474-4422(21)00361-6.
Chicago
Teunissen, Charlotte Elisabeth, Inge M.W. Verberk, Elisabeth H Thijssen, Lisa Vermunt, Oskar Hansson, Henrik Zetterberg, Wiesje M. van der Flier, Michelle M Mielke, and Marta del Campo. 2021. “Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.” The Lancet Neurology 21 (1): 66–77. https://doi.org/10.1016/s1474-4422(21)00361-6.
Harvard
Teunissen, C. E. et al. (2021) ‘Blood-based biomarkers for Alzheimer's disease: towards clinical implementation’, The Lancet Neurology, 21(1), pp. 66–77. doi:10.1016/s1474-4422(21)00361-6.
IEEE
C. E. Teunissen et al., “Blood-based biomarkers for Alzheimer's disease: towards clinical implementation,” The Lancet Neurology, vol. 21, no. 1, pp. 66–77, 2021, doi: 10.1016/s1474-4422(21)00361-6.
BibTeX
@article{teunissen2021blood,
title = {{Blood-based biomarkers for Alzheimer's disease: towards clinical implementation}},
author = {Teunissen, Charlotte Elisabeth and Verberk, Inge M.W. and Thijssen, Elisabeth H and Vermunt, Lisa and Hansson, Oskar and Zetterberg, Henrik and van der Flier, Wiesje M. and Mielke, Michelle M and del Campo, Marta},
journal = {The Lancet Neurology},
year = {2021},
volume = {21},
number = {1},
pages = {66--77},
doi = {10.1016/s1474-4422(21)00361-6},
url = {https://doi.org/10.1016/s1474-4422(21)00361-6}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 116 | |
| 2023 | 236 | |
| 2024 | 273 | |
| 2025 | 235 | |
| 2026 | 331 |
Its field-weighted citation impact is 21.45: it has been cited 21.45 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Alzheimer's disease
- blood-based biomarkers
- amyloid
- phosphorylated tau
- neurofilament light chain
- glial fibrillary acidic protein
- cerebrospinal fluid biomarkers
- amyloid PET
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Teunissen, C. E., Verberk, I. M., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2021). Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. The Lancet Neurology, 21(1), 66–77. https://doi.org/10.1016/s1474-4422(21)00361-6
How many times has this paper been cited?
1,193 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Amsterdam UMC (VU Amsterdam) - Institutional Repository: sign in and open the PDF from this page.
Who wrote this paper?
Charlotte Elisabeth Teunissen, Inge M.W. Verberk, Elisabeth H Thijssen, Lisa Vermunt, Oskar Hansson, Henrik Zetterberg, Wiesje M. van der Flier, Michelle M Mielke, Marta del Campo.
What is the DOI of this paper?
10.1016/s1474-4422(21)00361-6, permanently at https://doi.org/10.1016/s1474-4422(21)00361-6. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.